Going Defensive
In light of today’s negative reaction to the Federal Reserve’s so-called “Emergency” rate cut to 0% on Sunday (in reality, a panic move), we are advising additional defensive adjustments to our Model Fund Portfolio, reducing allocations to Energy and Consumer Discretionary ETFs increasing...
Read More
Bullish, but be Discerning
It’s been another solid week for the market, with the major indexes kiting higher and, while individual stocks were a bit more mixed and news-driven, most are acting just fine.
Overall, not much has really changed from a week ago—the vast of...
Read More
Congratulations to the Top Picks of 2019!
Our contributors did a stellar job for you last year. As you can see from the table below, our Top 5 Picks averaged 131% gains! And the rest were pretty good, too.
Last year, the markets recovered all they...
Read More
Market Views
Growth still the Sweet Spot
Our U.S. equity timing model remains on its November 1 buy signal. Small-cap growth remains stronger than small-cap value. There are no other consistent style preferences in relative strength. 10-year Treasury note yields have settled into the 1.80%-1.90% Our...
Read More
Market Views
Still bullish
The broad stock market continues to plow ahead, as $SPX has made new closing or intraday all-time highs on 10 of the last 14 days, including the last two. Thus, momentum is strong and the $SPX chart remains bullish. The $SPX $VIX...
Read More
Market Views
Quiet for Now
Stocks finished a relatively quiet session lower today, after trading on both sides of breakeven amid waning optimism over Friday's partial trade deal between Beijing and Washington. Reports emerged that China wishes to continue trade talks before finalizing the "phase deal,...
Read More
Market Views
Shifting to Value
We have a lot of market analysts who are at a loss to understand the rotation(s) that have enabled stocks to work higher (and challenge highs) even at the risk of crying alarms. The hedgers and many technicians do so, the...
Read More
Market Views
One Stock at a Time
The major indexes are tilted to the upside to start the week. However, under the surface, we’re continuing to see increasing selling pressure on most growth stocks, including a bunch of names from leading areas like software and While...
Read More
This regional supermarket also gets a nod from Zacks, scoring an ‘A’ on its VGM (value, growth, momentum score)
Read More
Market Views
No Longer Overbought
Technically, the S&P 500 has corrected most of an overbought condition with a 2.73% decline from its July 16 high. News-related volatility will likely continue as the market enters its least favorable season. But, sentiment gauges have begun to improve a..
Read More
Market Views
Be Ready for Profit-Taking
The S&P 500 and Dow Jones Industrial Average were little changed today on slightly negative breadth on the NYSE. Broad foreign equity ETFs (EFA, EEM, VEU) also had a quiet day. However, small and mid-cap ETFs fell about 1⁄2%.
The Russell...
Read More
Congrats to the Top Picks 2019, Mid-Year
Congratulations to our Top Picks for 2019! For the first half of the year, the Dow Jones Industrial Average was up 11.8%; the S&P 500 gained 14.3%, and the NASDAQ has returned 16.1%. But, as you can from...
Read More
Market Views
Mixed Signals
The $SPX chart is still bearish, because there are lower highs and lower lows on its chart. Oversold rallies typically carry from their lows up to and slightly above the declining 20-day moving average. That’s exactly what this rally has done far...
Read More
Market Views
Be Ready for Profit-Taking
I see yields and stocks falling considerably more than this in the months ahead. Likewise, I think gold’s countdown is nearing its end, prior to re-launching in more dramatic fashion its interrupted secular bull market.
But these moves—or at least of...
Read More
Market Views
Pare the Weak
The market has been under severe selling pressure for six days since the tariff tussle got underway two weekends ago, with today’s broad declines enough to crack the intermediate-term uptrend that began back in January. Big picture, it’s still a market,...
Read More
This gene therapy company has been getting lots of good attention from analysts, with coverage of the shares being initiated at Evercore ISI Group, with an ‘Outperform’ rating.
Read More
Market Views
Bullish, but Cautious
No basic changes for our overall views of a market capable of extending; but just in a guarded way. It measures higher, as its mostly fully-valued for big-cap leaders; hence vulnerable to shakeouts.
Equity markets, the Fed’s calmer monetary policy, generally to...
Read More
Market Views
Testing Resistance
Technically, the market experienced a two-week consolidation sufficient to resolve an overbought condition. With the return of some indicators to oversold territory, the S&P 500 could once again be positioned to test resistance above the 2800 level.
Timer Digest, P.O. Box 1688, CT...
Read More
Market Views
Caution Remains
Given that we’re fighting the 200-Day Moving Average; we can set-up for a bit of a pause. But it’s news-sensitive. So, for now, China may be a topic ‘beyond the interim pullback’ discussed as likely in February (or part of it, coming...
Read More
The shares of this company—in the midst of a turnaround—were recently upgraded at Jefferies, to ‘Buy’ and initiated at Mizuho, with a ‘Buy’ rating.
Read More